Series A Therapeutics Companies

Uniting science and technology to end silent suffering in Urology with accessible, reimbursable digital care

Asgard Therapeutics is a Biotechnology Company.

Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.

Kimia is a drug discovery company applying high throughput precision chemistry in combination.

Ciba Health offers a personalized digital therapeutics and virtual care platform.

Biolexis Therapeutics is a privately held biopharmaceutical company committed to developing novel targeted therapeutics.

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.